Drug Trial Radar · NCT03788434
Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Last checked: Nov 19, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
79
Actual
Start
Feb 8, 2019
Primary completion
Jun 2, 2021
Study completion Sep 15, 2021
Sponsor
- Lead sponsor
- Vedanta Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 27, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluated the safety and efficacy of VE303 for participants with primary C. difficile infection (pCDI) at high risk for recurrence or subjects with recurrent C. difficile infections (rCDI).
Conditions
- Clostridium Difficile Infection Recurrence
- Clostridium Difficile Infection
- Clostridium Difficile
- Clostridioides Difficile Infection Recurrence
- Clostridioides Difficile Infection
- Clostridioides Difficile
- CDI
Interventions
VE303Drug
VE303 is a live biotherapeutic product containing 8 clonal human commensal bacterial strains manufactured under Good Manufacturing Practices (GMP) conditions.
PlaceboDrug
Placebo capsules contained microcrystalline cellulose and were visually identical to VE303 capsules. Placebo capsules did not contain any VE303 Drug Product.
Primary outcomes
What the sponsor says the trial is designed to measure.
- CDI Recurrence Week 8Time frame: 8 weeks
Locations
37 sites in 2 countries. Site status is shown where the registry gives one.
Phoenix Clinical, LLC
Phoenix, Arizona
Mayo Clinic, Clinical Studies Unit
Phoenix, Arizona
NEA Baptist Clinic
Jonesboro, Arkansas
Alliance Research Institute
Canoga Park, California
University of California, Davis Medical Center
Sacramento, California
Ventura Clinical Trials
Ventura, California
Medical Research Center of Connecticut, LLC
Hamden, Connecticut
Innovative Research of West Florida
Clearwater, Florida
Gastro Florida
Clearwater, Florida
University of Florida
Gainesville, Florida
Guardian Angel Research Center
Tampa, Florida
Anne Arundel Health System Research Insitute
Annapolis, Maryland
Tufts Medical Center
Boston, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Covenant HealthCare
Saginaw, Michigan
Mayo Clinic
Rochester, Minnesota
New York University Langone Medical Center
New York, New York
Clinical Research of Gastonia
Gastonia, North Carolina
Southeastern Research Center
Winston-Salem, North Carolina
Toledo Institute of Clinical Research Inc
Toledo, Ohio
TruCare Internal Medicine and Infectious Diseases
DuBois, Pennsylvania
Frontier Clinical Research, LLC
Uniontown, Pennsylvania
Advanced Clinical Research-Be Well MD
Cedar Park, Texas
Texas Centers for Infectious Disease Associates
Fort Worth, Texas
Clinrx Research Joseph INC
Plano, Texas
Infectious Disease Associates of Central Virginia Infectious Disease
Lynchburg, Virginia
Seattle Infectious Disease Clinic
Seattle, Washington
Advanced Clinical Research-Spokane Gastroenterology
Spokane, Washington
Foothills Medical Centre - Microbial Health Clinic
Calgary, Alberta, Canada
CARe Clinic
Red Deer, Alberta, Canada
Moncton Hospital
Moncton, New Brunswick, Canada
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
Viable Clinical Research
Scarborough Village, Ontario, Canada
Q&T Research Chicoutimi
Chicoutimi, Quebec, Canada
CHU de Québec-Université Laval
Québec, Quebec, Canada
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-
Trois-Rivières, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.